Zobrazeno 1 - 3
of 3
pro vyhledávání: '"JM Castro Domínguez"'
Autor:
S Vázquez Blanco, JC De Miguel Bouzas, L Herrero Poch, L Villamayor Blanco, JM Castro Domínguez, S Fortes González
Publikováno v:
Section 1: Introductory statements and governance.
Background and importance High costs of biological medicines (BM) are a financial issue for hospitals. The arrival of biosimilar drugs (BS) improved their accessibilities by reducing their prices. Aim and objectives To analyse the costs of BM adminis
Autor:
S Vázquez Blanco, S Fortes González, L Villamayor Blanco, L Herrero Poch, JM Castro Domínguez, JC De Miguel Bouzas
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Alemtuzumab is a humanised monoclonal antibody that selectively targets CD52, indicated in adult patients with relapsing–remitting multiple sclerosis (RRMS). Aim and objectives To assess the effectiveness and safety of ale
Autor:
JM Castro Domínguez, H Fernández Vega, D Rodríguez Lorenzo, N. Martínez López de Castro, G. Piñeiro Corrales, M. Samartin Ucha, A. Paradela Carreiro
Publikováno v:
Patient safety and risk management.
Background High alert medications (HAM) are drugs that bear a heightened risk of causing significant patient harm when used in error. The Institute for Safe Medication Practices (ISMP) created and periodically updates a list of potential HAM for acut